Trials / Completed
CompletedNCT04246632
CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
Prospective, Open Label, Pilot Study of the CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (actual)
- Sponsor
- Capso Vision, Inc. · Industry
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This non-significant risk pilot study is designed to evaluate safety and performance of the CapsoCam® Colon capsule endoscope in patients who meet the eligibility criteria and are scheduled for colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CapsoCam Colon Capsule Endoscopy | CapsoCam® Colon is intended to provide visualization of the colon and the detection of colon polyps in adults. |
Timeline
- Start date
- 2020-01-25
- Primary completion
- 2021-02-25
- Completion
- 2021-03-15
- First posted
- 2020-01-29
- Last updated
- 2021-08-06
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04246632. Inclusion in this directory is not an endorsement.